Literature DB >> 16556694

Abnormal pulmonary function in adults with sickle cell anemia.

Elizabeth S Klings1, Diego F Wyszynski, Vikki G Nolan, Martin H Steinberg.   

Abstract

RATIONALE: Pulmonary complications of sickle cell anemia (Hb-SS) commonly cause morbidity, yet few large studies of pulmonary function tests (PFTs) in this population have been reported.
OBJECTIVES: PFTs (spirometry, lung volumes, and diffusion capacity for carbon monoxide [DLCO]) from 310 adults with Hb-SS were analyzed to determine the pattern of pulmonary dysfunction and their association with other systemic complications of sickle cell disease.
METHODS: Raw PFT data were compared with predicted values. Each subject was subclassified into one of five groups: obstructive physiology, restrictive physiology, mixed obstructive/restrictive physiology, isolated low DLCO, or normal. The association between laboratory data of patients with decreased DLCO or restrictive physiology and those of normal subjects was assessed by multivariate linear regression.
MEASUREMENTS AND MAIN RESULTS: Normal PFTs were present in only 31 of 310 (10%) patients. Overall, adults with Hb-SS were characterized by decreased total lung capacities (70.2 +/- 14.7% predicted) and DLCO (64.5 +/- 19.9%). The most common PFT patterns were restrictive physiology (74%) and isolated low DLCO (13%). Decreased DLCO was associated with thrombocytosis (p = 0.05), with hepatic dysfunction (elevated alanine aminotransferase; p = 0.07), and a trend toward renal dysfunction (elevated blood urea nitrogen and creatinine; p = 0.05 and 0.07, respectively).
CONCLUSIONS: Pulmonary function is abnormal in 90% of adult patients with Hb-SS. Common abnormalities include restrictive physiology and decreased DLCO. Decreased DLCO may indicate more severe sickle vasculopathy characterized by impaired hepatic and renal function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16556694      PMCID: PMC2662970          DOI: 10.1164/rccm.200601-125OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  36 in total

1.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

Review 2.  Sickle cell hemoglobin polymerization.

Authors:  W A Eaton; J Hofrichter
Journal:  Adv Protein Chem       Date:  1990

3.  Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.

Authors:  D Powars; J A Weidman; T Odom-Maryon; J C Niland; C Johnson
Journal:  Medicine (Baltimore)       Date:  1988-01       Impact factor: 1.889

4.  An assessment of lung volumes and gas transfer in sickle-cell anaemia.

Authors:  G J Miller; G R Serjeant
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

5.  The cooperative study of sickle cell disease: review of study design and objectives.

Authors:  M Gaston; W F Rosse
Journal:  Am J Pediatr Hematol Oncol       Date:  1982

6.  Subclinical ischaemic episodes during the steady state of sickle cell anaemia.

Authors:  N O Akinola; S M Stevens; I M Franklin; G B Nash; J Stuart
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

7.  Reference values and prediction equations for normal lung function in a non-smoking white urban population.

Authors:  C M Roberts; K D MacRae; A J Winning; L Adams; W A Seed
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

8.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

9.  Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD).

Authors:  M Gaston; J Smith; D Gallagher; Z Flournoy-Gill; S West; R Bellevue; M Farber; R Grover; M Koshy; A K Ritchey
Journal:  Control Clin Trials       Date:  1987-12

10.  Standardized single breath normal values for carbon monoxide diffusing capacity.

Authors:  R O Crapo; A H Morris
Journal:  Am Rev Respir Dis       Date:  1981-02
View more
  60 in total

1.  Local incentive spirometry improves peak expiratory flow rate in teenage sickle cell anaemia patients: a randomized pilot trial.

Authors:  A F Adeniyi; K S Saminu
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

2.  The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease.

Authors:  Jennifer M Knight-Madden; Terrence S Forrester; Norma A Lewis; Anne Greenough
Journal:  Lung       Date:  2010-07-20       Impact factor: 2.584

Review 3.  Asthma morbidity and treatment in children with sickle cell disease.

Authors:  Samuel O Anim; Robert C Strunk; Michael R DeBaun
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

4.  Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.

Authors:  Claudia R Morris; Hae-Young Kim; Elizabeth S Klings; John Wood; John B Porter; Felicia Trachtenberg; Nancy Sweeters; Nancy F Olivieri; Janet L Kwiatkowski; Lisa Virzi; Kathryn Hassell; Ali Taher; Ellis J Neufeld; Alexis A Thompson; Sandra Larkin; Jung H Suh; Elliott P Vichinsky; Frans A Kuypers
Journal:  Br J Haematol       Date:  2015-04-24       Impact factor: 6.998

Review 5.  Pulmonary complications of sickle cell disease.

Authors:  Andrew C Miller; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

Review 6.  Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Ian R Hambleton; Gavin Cho
Journal:  Cochrane Database Syst Rev       Date:  2016-05-20

7.  Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease.

Authors:  Yusuke Nakade; Tadashi Toyama; Kengo Furuichi; Shinji Kitajima; Noriyuki Ohkura; Akihiro Sagara; Yasuyuki Shinozaki; Akinori Hara; Kiyoki Kitagawa; Miho Shimizu; Yasunori Iwata; Hiroyasu Oe; Mikio Nagahara; Hiroshi Horita; Yoshio Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-12-15       Impact factor: 2.801

8.  Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease.

Authors:  Borna Mehrad; Marie D Burdick; Nancy J Wandersee; Kaushik S Shahir; Liyun Zhang; Pippa M Simpson; Robert M Strieter; Joshua J Field
Journal:  Blood Adv       Date:  2017-11-06

9.  Longitudinal analysis of pulmonary function in adults with sickle cell disease.

Authors:  Joshua J Field; Jeffrey Glassberg; Annette Gilmore; Joanna Howard; Sameer Patankar; Yan Yan; Sally C Davies; Michael R Debaun; Robert C Strunk
Journal:  Am J Hematol       Date:  2008-07       Impact factor: 10.047

10.  Pattern of chronic lung lesions in adults with sickle cell disease in Lagos, Nigeria.

Authors:  Adedoyin O Dosunmu; Rachael A Akinola; Josephine A Onakoya; Taiwo M Balogunt; Olufunke O Adeyeye; Akinsegun A Akinbami; Olanrewaju M Arogundade; Ayodeji T Brodie-Mends
Journal:  Caspian J Intern Med       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.